Next Article in Journal
Signalling and Bioactive Metabolites from Streptomyces sp. RK44
Next Article in Special Issue
Analytical Technique Optimization on the Detection of β-cyclocitral in Microcystis Species
Previous Article in Journal
Cinnamic Derivatives as Antitubercular Agents: Characterization by Quantitative Structure–Activity Relationship Studies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 25
Issue 3
10.3390/molecules25030457
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Neo-Aplysiatoxin A Isolated from Okinawan Cyanobacterium Moorea Producens

by
Mioko Kawaguchi
1,
Masayuki Satake
2,
Bo-Tao Zhang
1,
Yue-Yun Xiao
1,
Masayuki Fukuoka
1,
Hajime Uchida
3 and
Hiroshi Nagai
1,*
1
Department of Ocean Sciences, Tokyo University of Marine Science and Technology, Tokyo 108-8477, Japan
2
Department of Chemistry, The University of Tokyo, Tokyo 113-0033, Japan
3
National Research Institute of Fisheries Science, Japan Fisheries Research and Education Agency, Yokohama 236-8648, Japan
*
Author to whom correspondence should be addressed.
Molecules 2020, 25(3), 457; https://doi.org/10.3390/molecules25030457
Submission received: 25 December 2019 / Revised: 17 January 2020 / Accepted: 21 January 2020 / Published: 22 January 2020
(This article belongs to the Special Issue Bioactive Compounds from Cyanobacteria)
Browse Figures
Versions Notes

Abstract

:
A new aplysiatoxin derivative, neo-aplysiatoxin A (1), along with seven known compounds, neo-debromoaplysiatoxin A (2), dolastatin 3 (3), lyngbic acid (4), malyngamide M (5), hermitamide A (6), (−)-loliolide (7), and (+)-epiloliolide (8), was isolated from the Okinawan cyanobacterium Moorea producens. Their structures were elucidated on the basis of spectroscopic data, including high-resolution mass spectrometry and nuclear magnetic resonance. The compounds were evaluated for cytotoxic and diatom growth inhibition activities.

1. Introduction

In July of 2010, an outbreak of the marine cyanobacterium Moorea producens occurred in Okinawa, Japan. The sample used in this study was collected at that time and at that site. M. producens (formerly Lyngbya majuscula) is known as a producer of various toxic compounds that affect human health [1,2,3]. Previously, we initiated the analysis of toxic constituents in this sample. Our previous studies revealed that this sample contained aplysiatoxin and related compounds [4,5]. It is known that aplysiatoxins strongly potentiate protein kinase C (PKC) activity and that PKC activation by aplysiatoxins causes potent tumor-promoting actions [6,7,8,9,10]. The regulation of PKC activity has been shown to be a valuable developmental method for obtaining anti-cancer drugs [11,12]. In fact, simplified aplysiatoxin derivatives were shown to have anti-cancer activity [13,14]. Recently, it was revealed that neo-debromoaplysiatoxin (2) had an inhibitory effect on K+ channel activity, suggesting that their potential bioactivity could make aplysiatoxin derivatives an intriguing research subject [15]. As such, we continued to purify the compounds extracted from M. producens. Finally, the new aplysiatoxin derivative neo-aplysiatoxin A (1), along with seven known compounds (2–8, Figure 1), was isolated [15,16,17,18,19,20]. In this report, the isolation, structure elucidation, and bioactivities of these compounds are presented.

2. Results and Discussion

2.1. Structure Elucidation of the Compounds

Compound 1 was isolated as a colorless solid ([α]D17 + 16 (c 0.054, MeOH)). The nuclear magnetic resonance (1H NMR) spectrum showed that it was an aplysiatoxin-related compound. The molecular formula of 1 was deduced to be C32H45BrO10 ([M−H]− 667.2069 and 669.2047, calculated. 667.2112, and 669.2098, Figure S1), suggesting that it contained a bromophenol side chain. This was confirmed by the presence of a maximum at 281 nm (log ε 3.716) in the UV spectrum. The HSQC spectra (Figure S5) of 1 showed seven methyl groups (three singlets, three doublets, and a methoxy), five methylenes, two methines bonded to methyls, and a methine in the aliphatic region, as well as five oxygenated methines and three aromatic protons in the bromophenol side chain. Nine quaternary carbons (one aliphatic, two oxygenated, three aromatics in the bromophenol, two esters, and one ketone) were observed (Table 1). A ketone observed at δC 203.3 in methanol-d4 and a singlet methine (H-2) at δH 4.47, and HMBC correlations (Figure S6) from H-2 and Me-26 (δH 1.27) to the ketone (C-3) and from H-2 and two singlet methyls (Me-24 and Me-25) to an oxygenated quaternary carbon (C-7) at δC 83.1 suggested that 1 had a trimethylcyclohexanone structure analogous to 30-methyloscillatoxin D and neo-debromoaplysiatoxin A [4,15]. The partial structures H2-8 to H-9, H-10 (Me-23) to H-12 (Me-22), H2-14 to H-15, H-18 to H-19, and H2-28 to Me-31 were elucidated via 1H-1H COSY analysis (Figure 2a).
As seen with neo-debromoaplysiatoxin A (2) [15], an HMBC correlation (Figure 2a) from Me-26 to an oxygenated quaternary carbon at δC 74.4 indicated that a hydroxy group was attached to C-4 in the trimethylcyclohexanone. The proton chemical shifts of H2-8 (δH 2.05 and 2.19) and H-9 (δH 5.01) corresponded to a methylene group and an oxymethine group, respectively, indicating the absence of a double bond in a 6-membered ether ring, which has previously been observed in oscillatoxin D analogs [4]. HMBC correlations observed from H-2 to C-1, from H2-5 to C-4 and C-7, from H2-14 to C-12 and C-13, and from H-15 to C-17 and C-21 connected the partial structures from C-1 to C-26, and HMBC correlations from H2-28 to C-27 confirmed a pentanoate structure. The methoxy (Me-32) proton at δH 3.27 was confirmed by the HMBC spectrum to be bonded to C-15. Although HMBC correlations from H-9 to C-27 and H-29 to C-1 were not observed, the proton chemical shifts of H-9 at δH 5.01 and of H-29 at δH 5.10 suggested ester linkages between C-9 and C-27 and C-1 and C-29 respectively. These results suggested that 1 was a 17-brominated analog of neo-debromoaplysiatoxin A (2). The configuration of 1 was deduced by comparison of its proton chemical shifts with those of neo-debromoaplysiatoxin A (2), whose structure was confirmed by X-ray analysis [15]. The configuration at C-2, C-4, and C-7 was deduced from NOE correlations (Figure 2b, Figure S7) and the proton chemical shifts. The observed NOE correlations Me-25/H-5b and Me-26/H-5b suggested Me-25 and Me-26 resided in the same direction. The NOE correlations H-2/Me-24 and H-2/H8b indicated H-2, H2-8, and Me-24 positioned the α-orientation on the cyclohexanone. The proton chemical shifts of H-2, H2-5, H2-8, and Me-26 were in accordance with those of neo-debromoaplysiatoxin A [15]. These NOE correlations and proton chemical shifts indicated the configuration of the cyclohexanone shown in Figure 1. The proton coupling constants of 4.5 Hz for H-8a/H-9 and 4.5 Hz for H-8b/H-9, and NOE correlations H-9/H-10 and H-9/Me-23 indicated an equatorial orientation of H-9 on a 6-member ether ring. The large coupling constant (J = 10.8 Hz) of H-10/H-11 indicated that both H-10 and H-11 were axial protons. The small coupling constant (J = 1.7 Hz) and the NOE correlation H-11/H-12 suggested a gauche conformer of H-11/H-12 analogous with neo-debromoaplysiatoxin A. The NOE correlation H-29/H-30 and the proton coupling constant (J = 5.2 Hz) suggested the stereochemistry of H-29 and H-30 was syn. The proton chemical shift and the coupling constants (J = 7.5, 4.5 Hz) of H-15 were identical with those of aplysiatoxins possessing a bromophenol sidechain [4]. Therefore, the configuration at C-15 in 1 was deduced to be the same as that of aplysiatoxins. These analyses revealed 1 to be a 17-brominated analog of neo-debromoaplysiatoxin A (2). Therefore, we designated 1 as neo-aplysiatoxin A.
Seven known compounds were identified as neo-debromoaplysiatoxin A (2) [15], dolastatin 3 (3) [16], lyngbic acid (4) [17], malyngamide M (5) [18], hermitamide A (6) [19], (−)-loliolide (7) [20], and (+)-epiloliolide (8) [20] through comparison of their spectroscopic data with those reported in the literature. Compounds 2–4 and 6 were formerly reported from cyanobacteria [15,16,17,19]. Malyngamide M (5) had been isolated from a Hawaiian red alga [18]. However, it has been suggested that the true producer of malyngamide M (5) is a cyanobacterium growing epiphytically on the red alga [18]. Our study strongly supports this hypothesis. Loliolides 7 and 8 are norisoprenoids reported mainly from terrestrial higher plants and marine macroalgae [21]. This study represents the first occurrence of loliolides 7 and 8 isolated from cyanobacteria. These findings suggest that cyanobacteria are the true origins of loliolides isolated from marine animals such as sponges [22,23,24] and mollusks [25,26]. These results indicate that cyanobacteria may be the producers of many marine-originated compounds with unknown origins. The wide variety of compounds obtained in this study, in addition to the former studies on this cyanobacterium sample [4,5], highlighted once again that cyanobacterium Moorea producens is a rich source of unique secondary metabolites.

2.2. Biological Activities

These compounds were tested for cytotoxicity against L1210 mouse lymphoma cells and growth inhibition activity against a marine diatom Nitzchia amabilis. The results of the bioactivity tests are shown in Table 2. Neo-aplysiatoxin A (1) showed the same biotoxicities as neo-debromoaplysiatoxin A (2) at the tested doses (10 µg/mL). The bioactive potencies of 1 and 2 positioned them as the most active compounds when compared to the activities of aplysiatoxin and its related compounds in the same bioactivity tests [4,5]. It was previously reported that neo-debromoaplysiatoxin A (2) showed K+ channel inhibition activity [15]. Therefore, neo-aplysiatoxin A (1), which is closely related, could also be a K+ channel inhibitor. The mode of action of neo-aplysiatoxin A (1) is an intriguing research subject.
Dolastatin 3 (3) had been reported as an anticancer drug lead with its potent cytotoxicity [27,28], however in this study dolastatin 3 (3) showed no cytotoxicity against the L1210 cell line at a concentration of 10 µg/mL. Furthermore, in previous studies, synthetic dolastatin 3 also failed to show cytotoxicity [29]. Therefore, the cytotoxic activity of dolastatin 3 should be reconsidered.
Malyngamide M (5) and hermitamide A (6) both exhibited biotoxicity. In previous studies, malyngamide M (5) and hermitamide A (6) showed weak cytotoxicity against mouse neuroblastoma cells [18] and mild ichthyotoxic activity to goldfish [19] respectively.
Lyngbic acid (4), (−)-loliolide (7), and (+)-epiloliolide (8) showed no toxicity at the tested dose in this study.

3. Materials and Methods

3.1. General Experimental Procedure

HPLC was performed using a Hitachi Chromaster HPLC System (Hitachi High-Tech Science Co., Tokyo, Japan). HR-ESI-MS spectral data were collected using a Bruker micrOTOF QII (Bruker Co., Bremen, Germany) mass spectrometer. NMR spectra were recorded in methanol-d4 using a Bruker AVANCE III 600 spectrometer. Optical rotations were measured using a JASCO P-2100 (JASCO Co., Tokyo, Japan) with a 10 mm length cell. UV spectra were measured using a JASCO V-550 UV-spectrometer (JASCO Co., Tokyo, Japan). Bioassay results were recorded on a Model 550 microplate reader (Bio-Rad, Hercules, CA, USA).

3.2. Marine Cyanobacterium M. Producens

Samples of the marine cyanobacterium Moorea producens were collected from Kuba Beach, Nakagusuku, Okinawa, Japan, in July 2010. After freeze-drying, the samples were stored at −30 °C until the experiments were performed. The identification of the sample was accomplished via morphological observation under a microscope by one of the authors (M.F.). Moorea producens was a dominant cyanobacteria species in the sample. The sample also contained some unidentified diatoms. The voucher specimen (20100713-a) was deposited at the collection of Marine Natural Products Laboratory of Tokyo University of Marine Science and Technology.

3.3. Extraction and Isolation

A frozen sample of the cyanobacterium M. producens (dry weight: 0.87 kg) was soaked for several days in ethanol at room temperature. After filtration of the ethanol extract, the sample was extracted five times with methanol and once with acetone. The extracts were then combined and concentrated in vacuo to yield a residue (37.8 g), which was partitioned between methanol/water (4:1, v/v) and hexane. The 80% MeOH-soluble layer was concentrated to dryness, and the remaining sample was partitioned between distilled water and ethyl acetate (EtOAc). The EtOAc layer was evaporated to dryness. The distilled water layer was then dissolved with 1-butanol (BuOH) and separated into two extracts. Since the EtOAc layer of the extracts from the cyanobacterium M. producens showed the most potent bioactivity, this layer was separated using an open glass column (PEGASIL ODS, Senshu Co., Tokyo, Japan) measuring 20 × 120 mm with stepwise elution in 50%, 70%, 90%, and 100% methanol. The 70% methanol eluate was then purified via HPLC using a reverse-phase column (Cosmosil 5C18-AR-II, 10 × 250 mm, Nakalai Tesque Inc., Kyoto, Japan, solvent: 50% methanol, flow rate: 2.0 mL/min, UV: 210 nm). Finally, neo-aplysiatoxin A (1, 0.54 mg), neo-debromoaplysiatoxin A (2, 1.75 mg), dolastatin 3 (3, 3.93 mg), lyngbic acid (4, 2.16 mg), malyngamide M (5, 0.89 mg), hermitamide A (6, 1.01 mg), (−)-loliolide (7, 2.79 mg) and (+)-epiloliolide (8, 0.81 mg) were isolated.

3.4. Biological Tests

Cytotoxicity assays against mouse L1210 leukemia cells were carried out for the isolated compounds. The growth inhibition activities of the compounds (1–8) against the marine diatom Nitzschia amabilis were also evaluated. Both types of bioactive assays were performed using the XTT colorimetric reaction method, as previously reported [30,31].

Supplementary Materials

The following are available online at https://www.mdpi.com/1420-3049/25/3/457/s1, Figure S1: ESI-HRMS spectrum of neo-aplysiatoxin A in negative ion mode. Figure S2: 1H NMR spectrum of neo-aplysiatoxin A in methanol-d4. Figure S3: 13C NMR spectrum of neo-aplysiatoxin A in methanol-d4. Figure S4: 1H–1H COSY NMR spectrum of neo-aplysiatoxin A in methanol-d4. Figure S5: 1H–13C HSQC spectrum of neo-aplysiatoxin A in methanol-d4. Figure S6: 1H–13C HMBC spectrum of neo-aplysiatoxin A in methanol-d4, Figure S7. NOESY spectrum of neo-aplysiatoxin A in methanol-d4.

Author Contributions

Isolation—M.K., B.-T.Z., Y.-Y.X. Chemical analysis—H.N., M.K., M.S., H.U. Biological tests—M.K. Sample identification—M.F. Manuscript writing—H.N., M.S. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported partly by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research Grant Number 16K01911 and 19K06220 (Hiroshi Nagai) and 15K01798 (Masayuki Satake).

Acknowledgments

The authors thank Naomasa Oshiro, Setsuko Iwanaga, and Daijiro Kamiya of Okinawa Prefectural Institute of Health and Environment for the cyanobacteria sample collection. The authors would like to thank Miki Tsutsumi, Kaori Iida, Nao Kanda, and Minami Watanabe of Tokyo University of Marine Science and Technology for a part of experiments.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Engene, N.; Rottacker, E.C.; Kaštovský, J.; Byrum, T.; Choi, H.; Ellisman, M.H.; Komárek, J.; Gerwick, W.H. Moorea producens gen. nov., sp. nov. and Moorea bouillonii comb. nov., tropical marine cyanobacteria rich in bioactive secondary metabolites. Int. J. Syst. Evol. Microbiol. 2012, 62, 1171. [Google Scholar] [CrossRef] [PubMed]
  2. Codd, G.A.; Bell, S.G.; Kaya, K.; Ward, C.J.; Beattie, K.A.; Metcalf, J.S. Cyanobacterial toxins, exposure routes and human health. Eur. J. Phycol. 1999, 34, 405–415. [Google Scholar] [CrossRef]
  3. Osborne, N.J.; Shaw, G.R.; Webb, P.M. Health effects of recreational exposure to Moreton Bay, Australia waters during a Lyngbya majuscula bloom. Environ. Int. 2007, 33, 309–314. [Google Scholar] [CrossRef] [PubMed]
  4. Nagai, H.; Watanabe, M.; Sato, S.; Kawaguchi, M.; Xiao, Y.Y.; Hayashi, K.; Uchida, H.; Satake, M. New aplysiatoxin derivatives from the Okinawan cyanobacterium. Moorea Prod. Tetrahedron 2019, 75, 2486–2494. [Google Scholar]
  5. Nagai, H.; Sato, S.; Iida, K.; Hayashi, K.; Kawaguchi, M.; Uchida, H.; Satake, M. Oscillatoxin I: A new aplysiatoxin derivative, from a marine cyanobacterium. Toxins 2019, 11, 366. [Google Scholar] [CrossRef] [Green Version]
  6. Fujiki, H.; Suganuma, M.; Nakayasu, M.; Hoshino, H.; Moore, R.E.; Sugimura, T. The third class of new tumor promoters, polyacetates (debromoaplysiatoxin and aplysiatoxin), can differentiate biological actions relevant to tumor promoters. Gann 1982, 73, 495–497. [Google Scholar]
  7. Fujiki, H.; Tanaka, Y.; Miyake, R.; Kikkawa, U.; Nishizuka, Y.; Sugimura, T. Activation of calcium-activated, phospholipid-dependent protein kinase (protein kinase C) by new classes of tumor promoters: Teleocidin and debromoaplysiatoxin. Biochem. Biophys. Res. Commun. 1984, 120, 339–343. [Google Scholar] [CrossRef]
  8. Suganuma, M.; Fujiki, H.; Tahira, T.; Cheuk, C.; Moore, R.E.; Sugimura, T. Estimation of tumor promoting activity and structure-function relationships of aplysiatoxins. Carcinogenesis 1984, 5, 315–318. [Google Scholar] [CrossRef]
  9. Arcoleo, J.P.; Weinstein, I.B. Activation of protein kinase C by tumor promoting phorbol esters, teleocidin and aplysiatoxin in the absence of added calcium. Carcinogenesis 1985, 6, 213–217. [Google Scholar] [CrossRef]
  10. Nakamura, H.; Kishi, Y.; Pajares, M.A.; Rando, R.R. Structural basis of protein kinase C activation by tumor promoters. Proc. Natl. Acad. Sci. USA 1989, 86, 9672–9676. [Google Scholar] [CrossRef] [Green Version]
  11. Basu, A. The potential of protein kinase C as a target for anticancer treatment. Pharmacol. Therapeut. 1993, 59, 257–280. [Google Scholar] [CrossRef]
  12. Antal, C.E.; Hudson, A.M.; Kang, E.; Zanca, C.; Wirth, C.; Stephenson, N.L.; Trotter, E.W.; Gallegos, L.L.; Miller, C.J.; Furnary, F.B.; et al. Cancer-associated protein kinase C mutations reveal kinase’s role as tumor suppressor. Cell 2015, 160, 489–502. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Nakagawa, Y.; Yanagita, R.C.; Hamada, N.; Murakami, A.; Takahashi, H.; Saito, N.; Nagai, H.; Irie, K. A simple analogue of tumor-promoting aplysiatoxin is an antineoplastic agent rather than a tumor promoter: Development of a synthetically accessible protein kinase C activator with bryostatin-like activity. J. Am. Chem. Soc. 2009, 131, 7573–7579. [Google Scholar] [CrossRef] [PubMed]
  14. Irie, K.; Yanagita, R.C. Synthesis and biological activities of simplified analogs of the natural PKC ligands, bryostatin-1 and aplysiatoxin. Chem. Rec. 2014, 14, 251–267. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Han, B.N.; Liang, T.T.; Keen, L.J.; Fan, T.T.; Zhang, X.D.; Xu, L.; Zhao, Q.; Wang, S.P.; Lin, H.W. Two marine cyanobacterial aplysiatoxin polyketides, neo-debromoaplysiatoxin A and B, with K+ channel inhibition activity. Org. Lett. 2018, 20, 578–581. [Google Scholar] [CrossRef] [PubMed]
  16. Mitchell, S.S.; Faulkner, D.J.; Rubins, K.; Bushman, F.D. Dolastatin 3 and two novel cyclic peptides from a Palauan collection of Lyngbya majuscula. J. Nat. Prod. 2000, 63, 279–282. [Google Scholar] [CrossRef] [Green Version]
  17. Cardellina II, J.H.; Dalietos, D.; Marner, F.J.; Mynderse, J.S.; Moore, R.E. (−)-Trans-7(S)-methoxytetradec-4-enoic acid and related amides from the marine cyanophyte Lyngbya majuscula. Phytochem. 1978, 17, 2091–2095. [Google Scholar] [CrossRef]
  18. Kan, Y.; Fujita, T.; Nagai, H.; Sakamoto, B.; Hokama, Y. Malyngamides M and N from the Hawaiian red alga Gracilaria coronopifolia. J. Nat. Prod. 1998, 61, 152–155. [Google Scholar] [CrossRef]
  19. Tan, L.T.; Okino, T.; Gerwick, W.H. Hermitamides A and B, toxic malyngamide-type natural products from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2000, 63, 952–955. [Google Scholar] [CrossRef]
  20. Kuniyoshi, M. Germination inhibitors from the brown alga Sargassum crassifolium (Phaeophyta, Sargassaceae). Bot. Mar. 1985, 28, 501–504. [Google Scholar] [CrossRef]
  21. Grabarczyk, M.; Wińska, K.; Mączka, W.; Potaniec, B.; Anioł, M. Loliolide–the most ubiquitous lactone. Folia. Biol. Oecol. 2015, 11, 1–8. [Google Scholar] [CrossRef]
  22. Schmidtz, F.J.; Vanderah, D.J.; Hollenbeak, K.H.; Enwall, C.E.; Gopichand, Y.; SenGupta, P.K.; Hossain, M.B.; Van der Helm, D. Metabolites from the marine sponge Tedania ignis. A new atisanediol and several known diketopiperazines. J. Org. Chem. 1983, 48, 3941–3945. [Google Scholar] [CrossRef]
  23. Liu, D.; Xu, M.J.; Wu, L.J.; Deng, Z.W.; Lin, W.H. Norisoprenoids from the marine sponge Spheciospongia sp. J. Asian Nat. Prod. Res. 2009, 11, 811–816. [Google Scholar] [CrossRef] [PubMed]
  24. Yang, B.; Hu, J.; Lei, H.; Chen, X.Q.; Zhou, X.F.; Liu, Y.H. Chemical constituents of marine sponge Callyspongia sp. from the South China Sea. Chem. Nat. Compd. 2012, 48, 350–351. [Google Scholar] [CrossRef]
  25. Pettit, G.R.; Herald, C.L.; Ode, R.H.; Brown, P.; Gust, D.J.; Michel, C. The isolation of loliolide from an Indian ocean opisthobranch mollusc. J. Nat. Prod. 1980, 43, 752–755. [Google Scholar] [CrossRef] [PubMed]
  26. Pettit, G.R.; Kamano, Y.; Herald, C.L.; Fujii, Y.; Kizu, H.; Boyd, M.R.; Boettner, F.E.; Doubek, D.L.; Schmidt, J.M.; Chapuis, J.C.; et al. Isolation of dolastatins 10–15 from the marine mollusc Dolabella auricularia. Tetrahedron 1993, 49, 9151–9170. [Google Scholar] [CrossRef]
  27. Pettit, G.R.; Kamano, Y.; Brown, P.; Gust, D.; Inoue, M.; Herald, C.L. Antineoplastic agents. 3. Structure of the cyclic peptide dolastatin 3 from Dolabella auricularia. J. Am. Chem. Soc. 1982, 104, 905–907. [Google Scholar] [CrossRef]
  28. Pettit, G.R.; Kamano, Y.; Holzapfel, C.W.; Van Zyl, W.J.; Tuinman, A.A.; Herald, C.L.; Baczynskyj, L.; Schmidt, J.M. Antineoplastic agents. 150. The structure and synthesis of dolastatin 3. J. Am. Chem. Soc. 1987, 109, 7581–7582. [Google Scholar] [CrossRef]
  29. Shioiri, T.; Hamada, Y. Exploitation of new synthetic reagents and their application to the total synthesis of biologically active natural products. Yakugaku Zasshi 1988, 108, 1115–1128. [Google Scholar] [CrossRef] [Green Version]
  30. Kawabata, T.; Lindsay, D.J.; Kitamura, M.; Konishi, S.; Nishikawa, J.; Nishida, S.; Kamio, M.; Nagai, H. Evaluation of the bioactivities of water-soluble extracts from twelve deep-sea jellyfish species. Fish. Sci. 2013, 79, 487–494. [Google Scholar] [CrossRef] [Green Version]
  31. Jiang, W.; Akagi, T.; Suzuki, H.; Takimoto, A.; Nagai, H. A new diatom growth inhibition assay using the XTT colorimetric method. Comp. Biochem. Phys. C 2016, 185, 13–19. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: Samples of the compounds are not available from the authors.
Molecules 25 00457 g001 550
Figure 1. Structures of compounds 1 to 8.
Figure 1. Structures of compounds 1 to 8.
Molecules 25 00457 g001
Molecules 25 00457 g002 550
Figure 2. (a) Observed COSY, TOCSY, and HMBC correlations of 1, (b) NOE correlations of 1.
Figure 2. (a) Observed COSY, TOCSY, and HMBC correlations of 1, (b) NOE correlations of 1.
Molecules 25 00457 g002
Table
Table 1. NMR data for neo-aplysiatoxin A (1) in methanol-d4 (600 MHz for 1H and 150 MHz for 13C).
Table 1. NMR data for neo-aplysiatoxin A (1) in methanol-d4 (600 MHz for 1H and 150 MHz for 13C).
No.δH Multip. (J in Hz)δCNo.δH Multip. (J in Hz)δC
1 168.9, C16 142.8, C
24.47 s55.6, CH17 111.6, C
3 203.3, C187.35 d (8.7)132.9, CH
4 74.4, C196.65 dd (8.6, 3.1)115.9, CH
5a1.62 d (14.5)48.5, CH220 157.5, C
5b2.09 d (14.5) 216.95 d (3.0)114.0, CH
6 41.6, C220.83 (3H) d (3.3)10.5, CH3
7 83.1, C230.84 (3H) d (3.6)12.2, CH3
8a2.05 dd (15.9, 4.5)30.7, CH2241.33 (3H) s23.5, CH3
8b2.19 dd (15.9, 4.5) 251.01 (3H) s24.5, CH3
95.01 m71.8, CH261.27 (3H) s24.0, CH3
101.67 m32.9, CH27 171.0, C
114.22 dd (10.8, 1.7)73.8, CH28a2.67 dd (13.5, 4.3)34.3, CH2
121.58 m34.2, CH28b3.13 dd (13.5, 8.2)
13a1.45 m30.4, CH2295.10 ddd (8.2, 5.2, 4.4)73.5, CH
13b1.45 m 303.93 m67.4, CH
14a1.69 m34.9, CH2311.25 (3H) d (6.4)17.5, CH3
14b1.69 m 323.27 (3H) s56.1, CH3
154.54 dd (7.5, 4.5)82.6, CH
Table
Table 2. Inhibition rates on cytotoxicity and diatom growth inhibition assays.
Table 2. Inhibition rates on cytotoxicity and diatom growth inhibition assays.
CompoundCytotoxicity (%)Diatom Growth Inhibition (%)
18590
28585
300
400
59055
62090
700
800
L1210 mouse lymphoma cells were used for the cytotoxicity assay. A marine diatom Nitzschia amabilis was used for the diatom growth inhibition assay. The values indicate inhibition rates at the sample concentration of 10 µg/mL.

Share and Cite

MDPI and ACS Style

Kawaguchi, M.; Satake, M.; Zhang, B.-T.; Xiao, Y.-Y.; Fukuoka, M.; Uchida, H.; Nagai, H. Neo-Aplysiatoxin A Isolated from Okinawan Cyanobacterium Moorea Producens. Molecules 2020, 25, 457. https://doi.org/10.3390/molecules25030457

AMA Style

Kawaguchi M, Satake M, Zhang B-T, Xiao Y-Y, Fukuoka M, Uchida H, Nagai H. Neo-Aplysiatoxin A Isolated from Okinawan Cyanobacterium Moorea Producens. Molecules. 2020; 25(3):457. https://doi.org/10.3390/molecules25030457

Chicago/Turabian Style

Kawaguchi, Mioko, Masayuki Satake, Bo-Tao Zhang, Yue-Yun Xiao, Masayuki Fukuoka, Hajime Uchida, and Hiroshi Nagai. 2020. "Neo-Aplysiatoxin A Isolated from Okinawan Cyanobacterium Moorea Producens" Molecules 25, no. 3: 457. https://doi.org/10.3390/molecules25030457

Article Metrics

Back to TopTop